CD8A and lymphopenia: In spite of causing lymphopenia, SARS-CoV-2 is capable of eliciting IgG and IgA antibody responses, as well as CD4+ (predominantly Th1) and CD8+ T cell responses in the majority of infected individuals with mild symptoms [10,11].